CROI 2026: Characterization of HIV Acquisitions on Long-Acting Cabotegravir PrEP from ImPrEP CAB Brasil
Urvi M Parikh1, Brenda Hoagland2, Jana L. Jacobs1, Carolina Coutinho2, Marcos Benedetti2, Dianna L. Hoeth1, Asma Naqvi1, Amy L. Heaps1,…
Category: Information
CROI 2026: Balancing STI Prevention and Antibiotic Use – Simulated Doxy-PEP Implementation Strategies in the ImPrEP Study
Mayara Secco Torres da Silva1, Ronaldo Ismério Moreira1, Iuri Costa Leite1, Marcelo Cunha1, Thiago Silva Torres1, Carolina Coutinho1, Brenda Hoagland1,…
ABRASCÃO 2025 Substance Use and Adherence to Oral PrEP Among MSM, Transvestites, and Transgender Women in Latin America: Results from the ImPrEP Study
Latin America is experiencing an increase in the number of new HIV infections among key populations, including in Brazil, despite…
ABRASCÃO 2025 Mental health and substance use among young people from sexual and gender minorities: findings from the ImPrEP CAB Brazil study
Mental health aspects and substance use can affect adherence to pre-exposure prophylaxis (PrEP) for HIV, thus increasing vulnerability to infection…
ABRASCÃO 2025 ImPrEP CAB Brazil: Analyzing PrEP Choices and Increasing Coverage of Prophylaxis with Injectable Cabotegravir in Key Young Populations
Pre-exposure prophylaxis (PrEP), in the daily oral modality, is highly effective in preventing HIV, but adherence to the medication remains…
High syphilis incidence among PrEP – adherent men who have sex with men and transgender women in Peru
Article by ImPrEP published at Journal of International AIDS Society, in 2025, September - https://onlinelibrary.wiley.com/doi/10.1002/jia2.70002
IAS 2025: Implementation of long-acting PrEP in real world settings – the ImPrEP project (SATELLITE SYMPOSIUM)
https://programme.ias2025.org/Programme/Session/195
IAS 2025: Current and Prior PrEP Use and Associated Factors among Sexual and Gender Minorities (SGM) from Brazil, Mexico and Peru (POSTER)
https://programme.ias2025.org/Abstract/Abstract/?abstractid=5353
IAS 2025: Understanding preferences and transitioning between oral and injectable PrEP: insights from ImPrEP CAB Brasil Study (POSTER)
https://programme.ias2025.org/Abstract/Abstract/?abstractid=3917
IAS 2025: Mpox diagnosis and vaccination among gay and other men who have sex with men
and transgender women in Brazil: results from a large nationwide online survey (POSTER)
https://programme.ias2025.org/Abstract/Abstract/?abstractid=6892